Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eucalyptus refers to the genus of flowering trees and shrubs, primarily known for its essential oil, eucalyptus oil, which is extracted from its leaves. The main active component of eucalyptus oil is 1,8-cineole, also known as eucalyptol. This natural product is widely utilized in over-the-counter (OTC) medications and traditional remedies for its diverse therapeutic properties. It is recognized for its potent anti-inflammatory, antimicrobial (antibacterial, antifungal, antiviral), and decongestant effects. Eucalyptus oil is commonly found in products aimed at alleviating symptoms of respiratory conditions such as coughs, colds, sinusitis, and sore throats, where it helps to clear airways, reduce mucus, and soothe irritation. It also exhibits analgesic properties and has been explored for its antidiabetic potential.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eucalyptus.